RadiotherapyAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy DosageRadiotherapy, AdjuvantChemotherapy, AdjuvantRadiotherapy, ConformalCombined Modality TherapyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyTreatment OutcomeCisplatinDose FractionationAntineoplastic AgentsRadiation InjuriesNeoplasm StagingDisease-Free SurvivalRadiotherapy, Computer-AssistedDoxorubicinCyclophosphamideRadiotherapy, Image-GuidedNeoplasm Recurrence, LocalSurvival AnalysisSurvival RateNeoadjuvant TherapyLung NeoplasmsBreast NeoplasmsPrognosisHead and Neck NeoplasmsEtoposideRadiation OncologyChemoradiotherapyFollow-Up StudiesBrain NeoplasmsDrug Administration ScheduleCarcinoma, Squamous CellNeoplasmsDose-Response Relationship, RadiationBrachytherapyVinblastineRadiosurgeryCarboplatinMethotrexateNasopharyngeal NeoplasmsHodgkin DiseaseBleomycinCarcinoma, Non-Small-Cell LungDacarbazineCranial IrradiationAntineoplastic Agents, AlkylatingSalvage TherapyPaclitaxelTime FactorsInduction ChemotherapyAdenocarcinomaRectal NeoplasmsIfosfamideAntimetabolites, AntineoplasticRadiation ToleranceDeoxycytidineTaxoidsRadiation-Sensitizing AgentsNeoplasm MetastasisPalliative CareKaplan-Meier EstimateOrgans at RiskProspective StudiesNeoplasms, Second PrimaryOrganoplatinum CompoundsTesticular NeoplasmsTomography, X-Ray ComputedLomustineCarcinomaDrug Resistance, NeoplasmRetrospective StudiesLymphatic MetastasisProstatic NeoplasmsLymphoma, Non-HodgkinBone NeoplasmsMastectomy, SegmentalRadiation PneumonitisParticle AcceleratorsPelvic NeoplasmsLaryngeal NeoplasmsClinical Trials as TopicRadiometrySarcomaRadiation DosageCytarabineAnthracyclinesAntineoplastic Agents, PhytogenicMastectomyFeasibility StudiesChemotherapy, Cancer, Regional PerfusionNeoplasms, Radiation-InducedRecurrenceVindesineTumor Markers, BiologicalEsophageal NeoplasmsRadiodermatitis